Mannkind Corp
MNKD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899460
In the last 90 days, Mannkind Corp insiders filed 0 open-market purchases and 4 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $776.3M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $597.1K in total
- 4
- 13F holdersQ2 2026, +11 vs. previous quarter
- 259
- 13F valueReported value at the end of Q2 2026
- $776.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MNKD, Q2 2026
No superinvestor reported holding MNKD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Mannkind Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)8:00 PM ET | Sep 10 | 4 days | Binder Steven B.Director | SSaleCommon Stock, $0.01 Par Value | −33.6K | $3.81 | −$127.9K | −4.3%752.3K after | 10b5-1 |
| Aug 10, 2026 (view filing)8:44 PM ET | Aug 7 | 3 days | Binder Steven B.Director | SSaleCommon Stock, $0.01 Par Value | −39.1K | $4.06 | −$158.5K | −4.7%785.9K after | 10b5-1 |
| Jul 17, 2026 (view filing)9:43 PM ET | Jul 17 | Same day | Thomson DavidEVP Genl Counsel & Secretary | SSaleCommon Stock, $0.01 Par Value | −24.1K | $4.05 | −$97.6K | −2.9%797.6K after | 10b5-1 |
| Jul 17, 2026 (view filing)9:42 PM ET | Jul 17 | Same day | Binder Steven B.Director | SSaleCommon Stock, $0.01 Par Value | −52.5K | $4.06 | −$213.1K | −6.0%824.9K after | 10b5-1 |
| May 13, 2026 (view filing) | May 12 | 1 day | Binder Steven B.Director | SSaleCommon Stock, $0.01 Par Value | −16.9K | $3.29 | −$55.7K | −2.1%808.0K after | 10b5-1 |
| May 13, 2026 (view filing) | May 12 | 1 day | Thomson DavidEVP Genl Counsel & Secretary | SSaleCommon Stock, $0.01 Par Value | −3.03K | $3.29 | −$9.98K | −0.4%826.3K after | 10b5-1 |
| Jan 9, 2026 (view filing) | Jan 8 | 1 day | Tross Stuart AChief People & Workpl Officer | SSaleCommon Stock, $0.01 Par Value | −47.0K | $6.33 | −$297.5K | −4.6%985.0K after | 10b5-1 |
| Dec 19, 2025 (view filing) | Dec 17 | 2 days | Castagna MichaelChief Executive Officer | SSaleCommon Stock, $0.01 Par Value | −65.8K | $6.01 | −$395.5K | −2.6%2.50M after | 10b5-1 |
| Dec 16, 2025 (view filing) | Dec 12-16 | 4 days | Castagna MichaelChief Executive Officer | SSaleCommon Stock, $0.01 Par Value | −42.1K | $6.00 | −$252.7K | −1.7%2.50M after | 2 lots10b5-1 |
| Dec 4, 2025 (view filing) | Dec 2 | 2 days | Castagna MichaelChief Executive Officer | SSaleCommon Stock, $0.01 Par Value | −107.9K | $5.57 | −$601.1K | −4.1%2.50M after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Mannkind Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 32,133,223 | $136.9M | 0.00% | +3,532,225+12.4% | Added |
| Rubric Capital Management LP | 18,000,000 | $76.7M | 0.70% | +14,379,587+397.2% | Added |
| State Street Corp | 16,174,043 | $68.9M | 0.00% | −2,509,440−13.4% | Reduced |
| Vanguard Capital Management LLC | 13,169,392 | $56.1M | 0.00% | +278,326+2.2% | Added |
| Geode Capital Management, LLC | 7,947,203 | $33.9M | 0.00% | +442,056+5.9% | Added |
| Wellington Management Group LLP | 7,844,807 | $33.4M | 0.01% | +4,561,628+138.9% | Added |
| Frazier Life Sciences Management, L.P. | 6,600,000 | $28.1M | 0.61% | +700,000+11.9% | Added |
| Deep Track Capital, LP | 6,000,000 | $25.6M | 0.38% | +6,000,000 | New |
| 180 Wealth Advisors, LLC | 4,959,351 | $21.1M | 2.12% | +667,648+15.6% | Added |
| FMR LLC | 4,101,046 | $17.5M | 0.00% | +620,082+17.8% | Added |